# OnCo record cabergoline (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/cabergoline/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "cabergoline" ;
  schema:name "Cabergoline"@en ;
  schema:alternateName "Cabaser"@en, "Dostinex" ;
  schema:description "Cabergoline is a tablet taken once or twice a week that shrinks prolactin-secreting pituitary tumours and normalises hormone levels in most patients, so surgery is reserved for the few whose tumours resist or who cannot tolerate it."@en ;
  schema:url <https://onco.cc/drugs/cabergoline/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Cabergoline> ;
  schema:citation <https://en.wikipedia.org/wiki/Cabergoline> ;
  onco:status "approved" ;
  onco:tag "subtype-drugs-wave" ;
  onco:modality "Oral long-acting dopamine D2 receptor agonist" ;
  onco:approval "US 1996: Hyperprolactinaemic disorders, idiopathic or due to pituitary adenomas" ;
  onco:related <https://onco.cc/drugs/bromocriptine/> ;
  onco:cancers <https://onco.cc/cancers/pituitary-tumours/> ;
  onco:targets <https://onco.cc/targets/drd2/> ;
  onco:companies <https://onco.cc/companies/pfizer/> .